# Giuseppe Giaccone

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/giuseppe-giaccone/

## Facts

| Field | Value |
| --- | --- |
| Citations | 74,399 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 130 |
| i10-index | 600 |
| Last Known Institution | Cornell University |
| OpenAlex ID | https://openalex.org/A5022063365 |
| ORCID iD | https://orcid.org/0000-0002-5023-7562 |
| Works | 1,117 |

## Researcher papers

- [The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer](https://scholariq.org/papers/the-iaslc-lung-cancer-staging-project-proposals-for-revision-of-the-tnm-stage/)
- [Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs](https://scholariq.org/papers/using-multiplexed-assays-of-oncogenic-drivers-in-lung-cancers-to-select-targeted/)
- [Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC](https://scholariq.org/papers/atezolizumab-for-first-line-treatment-of-pd-l1-selected-patients-with-nsclc/)
- [The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer](https://scholariq.org/papers/the-iaslc-lung-cancer-staging-project-proposals-for-coding-t-categories-for/)
- [The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer](https://scholariq.org/papers/the-iaslc-lung-cancer-staging-project-external-validation-of-the-revision-of-the/)
- [The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer](https://scholariq.org/papers/the-international-association-for-the-study-of-lung-cancer-lung-cancer-staging/)
- [Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study](https://scholariq.org/papers/pembrolizumab-in-patients-with-thymic-carcinoma-a-single-arm-single-centre-phase/)
- [The Integrated Genomic Landscape of Thymic Epithelial Tumors](https://scholariq.org/papers/the-integrated-genomic-landscape-of-thymic-epithelial-tumors/)
- [Refining the treatment of NSCLC according to histological and molecular subtypes](https://scholariq.org/papers/refining-the-treatment-of-nsclc-according-to-histological-and-molecular-subtypes/)
- [Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial](https://scholariq.org/papers/sunitinib-in-patients-with-chemotherapy-refractory-thymoma-and-thymic-carcinoma/)
- [A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors](https://scholariq.org/papers/a-specific-missense-mutation-in-gtf2i-occurs-at-high-frequency-in-thymic/)
- [Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors](https://scholariq.org/papers/phase-ii-study-of-belinostat-in-patients-with-recurrent-or-refractory-advanced/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Myasthenia Gravis and Thymoma](https://scholariq.org/topics/myasthenia-gravis-and-thymoma/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)

## Researcher university

- [Cornell University](https://scholariq.org/institutions/cornell-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.